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ABSTRACT 
Congenital anomalies of the kidneys and urinary tract (CAKUT) are the most common cause of 
chronic kidney disease in the first three decades of life. Identification of monogenic mutations that 
cause CAKUT permits insights into related disease mechanisms. However, for most cases of 
CAKUT the causative mutation remains unknown. We identified a kindred with an autosomal-
dominant form of CAKUT. By whole exome sequencing, we identified a heterozygous truncating 
mutation (c.279delG, p.Trp93fs*) of the NRIP1 gene in all seven affected members. NRIP1 
encodes a nuclear receptor transcriptional co-factor, which directly interacts with the retinoic acid 
receptors to modulate retinoic acid transcriptional activity. Functional studies revealed that the 
NRIP1 altered protein does not translocate to the nucleus, does not interact with retinoic acid 
receptor alpha (RARα) and fails to inhibit retinoic acid dependent transcriptional activity. In 
addition, we show that NRIP1 expression as well as its binding to retinoic acid receptor alpha, is 
enhanced in the presence of retinoic acid. Expression and knockdown experiments in Xenopus 
laevis further confirmed a role for NRIP1 in renal development. These data indicate that dominant 
NRIP1 mutations cause CAKUT by interference with retinoic acid transcriptional signaling, thus 
shedding light on the well documented association between abnormal vitamin A levels and renal 
malformations, and suggest a possible gene environment pathomechanism.  
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INTRODUCTION  
Congenital anomalies of the kidneys and urinary tract (CAKUT) constitute the most frequent cause 
of chronic kidney disease in the first three decades of life, accounting for ~50% of all cases1; 2. 
CAKUT comprises a wide range of structural malformations that result from defects in the 
morphogenesis of the kidneys and/or the urinary tract3-6. The pathologic basis of CAKUT lies in the 
disturbance of normal kidney development, primarily resulting from mutations in genes that direct 
this process. Most gene products that cause CAKUT in humans or mice if altered are transcription 
factors involved in protein-protein interactions and form large transcription complexes7-13. These 
monogenic forms of CAKUT are often inherited in an autosomal dominant manner and exhibit the 
clinical features of incomplete penetrance and variable expressivity. These features of loose 
genotype/phenotype correlation, as well as extensive genetic heterogeneity, has rendered gene 
discovery in CAKUT very difficult. Although ~30 CAKUT genes have been identified1; 2; 14, 
approximately 85% of patients with CAKUT do not have mutations in any known genes15; 16. 
Hence, a remaining challenge is to identify the missing components of the pathogenesis of 
CAKUT, in order to understand how those proteins and transcription factor complexes exert their 
developmental and tissue specific functions.  
    In addition to the clear importance of genetic factors on the proper development of the kidney 
and urinary tract, numerous studies also support the influence of environmental factors on normal 
and abnormal kidney development 4; 17, suggesting that the pathogenesis of CAKUT can be 
multifactorial, likely due to a complex interplay between genes and environment. The most 
prominent example for this is the effect of retinoic acid, the active form of vitamin A, on the kidneys 
and urinary tract during development. During fetal life, nephrogenesis is influenced by retinoic acid 
level, such that even moderate maternal vitamin A alterations in either direction can cause CAKUT 
in humans and rodents18; 19. In addition, elegant studies of murine kidney development by 
Mendelsohn et al. have shown that inactivation of genes in the retinoic acid pathway causes 
CAKUT in mice 20-22.  
   To gain further insights into the pathogenesis of CAKUT, we investigated a three generation 
family with renal malformations by whole exome sequencing (WES). We here identify dominant 
mutations in the transcription co-factor NRIP1 gene as causing human autosomal dominant 
CAKUT by interference with retinoic acid transcriptional signaling, thus shedding light on the well 
documented association between retinoic acid and renal malformations.  
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METHODS  
Study participants 
Following informed consent, we obtained clinical data, pedigree data, and blood samples from 
individuals with CAKUT from worldwide sources using a standardized questionnaire.  Approval for 
human subjects’ research was obtained from the Institutional Review Boards of the University of 
Michigan, Boston Children’s Hospital, Sheba Medical Center, and from other relevant local Ethics 
Review Boards. Informed consent was obtained from the individuals and/or parents, as 
appropriate. The diagnosis of CAKUT was made by (pediatric) nephrologists and/or urologists 
based on relevant imaging.  
 
Whole exome sequencing 
To identify a causative mutated gene for CAKUT we investigated family members from a four-
generation Yemenite-Jewish family (Fig. 1) with an autosomal dominant form of CAKUT 
characterized predominantly by lower urinary tract involvement, renal hypodysplasia and/or ectopia 
(Table 1). DNA samples from 6 affected individuals (Fig. 1) were subjected to whole exome 
sequencing (WES) as established previously using Agilent SureSelect™ human exome capture 
arrays (Life Technologies) with next generation sequencing (NGS) on an Illumina™ sequencing 
platform. Sequence reads were mapped against the human reference genome (NCBI build 
37/hg19) using CLC Genomics Workbench (version 6.5.1) software (CLC bio). Mutation calling 
under an autosomal dominant model was performed by geneticists and cell biologists, who had 
knowledge regarding clinical phenotypes, pedigree structure, genetic mapping, and WES 
evaluation (Table S1) and in line with proposed guidelines.23; 24 Sequence variants that remained 
after the WES evaluation process were examined for segregation.  
 
Whole exome sequencing (WES) analysis 
Following WES, genetic variants were first filtered to retain only heterozygous, non-synonymous 
variants that were shared between the 6 affected relatives of family H subjected to WES. Second, 
filtering was performed to retain only alleles with a minor allele frequency (MAF) <0.1%, a widely 
accepted cutoff for autosomal dominant disorders.25; 26 MAF was estimated using combined 
datasets incorporating all available data from the 1,000 Genomes Project, the Exome Variant 
Server (EVS) project, dbSNP138, and the Exome Aggregation Consortium (ExAC). Third, 
observed sequence variants were analyzed using the UCSC Human Genome Bioinformatics 
Browser for the presence of paralogous genes, pseudogenes, or misalignments. Fourth, we 
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scrutinized all variants with MAF<0.1% within the sequence alignments of the CLC Genomic 
Workbench™ software program for poor sequence quality and for the presence of mismatches that 
indicate potential false alignments. Fifth, we employed web based programs to assess variants for 
evolutionary conservation, to predict the impact of disease candidate variants on the encoded 
protein, and to predict whether these variants represented known disease causing mutations. 
Finally, Sanger sequencing was performed to confirm the remaining variants in original DNA 
samples and to test for familial segregation of phenotype with genotype. Variants were also tested 
for absence from in-house control populations of 200 individuals with nephronophthisis, and 429 
individuals with steroid resistant nephrotic syndrome.  
 
Copy number variants analysis 
One individual from the index family (Family H individual III8; Fig. 1A) was analyzed for copy 
number variations. Genome-wide genotyping for copy number variant (CNV) analysis was 
performed on an ________ platform as previously described. Genotype calls and quality-control 
analyses were performed with Genome Studio v.2010.3 (Illumina) and PLINK software. The CNV 
calls were determined with generalized genotyping methods implemented in the PennCNV 
program. CNVs were mapped to the human reference genome hg18 and annotated with UCSC 
RefGene and RefExon (CNVision program25).(Hagith Yonath please fill)  
 
High-Throughput NRIP1 mutation analysis  
Massively parallel sequencing of all NRIP1 exons was performed in ~600 individuals from ~300 
different families with CAKUT from different pediatric nephrology centers worldwide using 
microfluidic PCR (Fluidigm™) and next-generation sequencing (MiSeq™, Illumina) as described 
previously. Variants were filtered against public variant databases 
(http://evs.gs.washington.edu/EVS) and only novel heterozygous variants were considered, 
confirmed by Sanger sequencing, and tested for segregation with the CAKUT phenotype.  
 
cDNA cloning 
Full-length human NRIP1 cDNA and retinoic acid receptor alpha (RARα) cDNAs were subcloned 
by PCR from full-length cDNA (cDNA clone MGC:_______ IMAGE:______ and cDNA clone 
MGC:____ IMAGE:_____, respectively). Expression vectors were generated using LR Clonase 
(Invitrogen) according to the manufacturer’s instructions. The following expression vectors were 
used in this study: pRK5-N-Myc, pcDNA6.2-N-GFP, and p____-FLAG (ASK DANIELA WHAT 
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FLAG EXPRESSION VECTOR IS).  Mutagenesis was performed using the QuikChange II XL site-
directed mutagenesis kit (Agilent Technologies) to generate a clone with the NRIP1 mutation 
identified in Family H. 
 
Cell culture, transient transfections, and retinoic acid treatment  
The experiments described were performed in HEK293 cells purchased from the American Type 
Culture Collection biological resource center. For transient transfections, HEK293 cells were 
seeded at 60-70% confluency in Dulbecco’s modified Eagle’s medium, supplemented with 10% 
fetal calf serum and 1% penicillin/streptomycin and grown overnight. Transfections were carried 
out using Lipofectamine2000 (Invitrogen) and OptiMEM (????) following the manufacturer’s 
instructions. For experiments involving treatment with retinoic acid (RA), HEK293 cells were 
treated with 500 nM RA 24 hours after transfection. Experiments were then carried out 24 hours 
after continuous treatment with RA.  
 
NRIP1 reporter gene assays 
For reporter assays (Dual luciferase reporter assay system, Promega) HEK293 cells were seeded 
in 24-well dishes and transfected with constant amounts of reporter plasmids (kind gift from Li-Na 
Wei) and 100 ng of pRL-TK Renilla Luciferase™ for normalization. The total amount of expression 
plasmid was kept constant by adding empty pcDNA6.2-N-GFP. Per transfection, 500 ng of 
pGL3.RARE ()-luciferase reporter plasmid (which harbors four retinoic acid response elements: 
_______________) and 500 ng of pcDNA6.2-N-GFP.NRIP1 expression plasmid were used. For 
competition experiments, the amount of pcDNA6.2-N-GFP.NRIP1_WT was held constant and 
increasing amounts of pcDNA6.2-N-GFP.NRIP1_p.Trp93fs* was added. Firefly luciferase™ and 
Renilla luciferase™ activities were measured 24 hours after transfection. All transfections were 
performed in triplicate, and individual experiments were repeated at least three times. After 
normalization, the mean luciferase activities and standard deviations were plotted as “fold 
activation” when compared with the empty expression plasmid. p values were determined using 
the Student’s t-test. 
 
Immunofluorescence and confocal microscopy in cell lines 
For immunostaining, HEK293 cells were seeded on Fibronectin-coated coverslips in 6-well plates. 
After 16-24 hours, cells were transiently transfected using Lipofectamine2000 (Invitrogen) following 
the manufacturer's instructions. Experiments were performed 24–48 hours after transfection. Cells 
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were fixed for 15 min using 4% paraformaldehyde and permeabilized for 10 min using 0.1 (? 
Double check this) % Triton X-100. After blocking with 10% donkey serum + BSA, cells were 
incubated with primary antibody overnight at 4°C. The following day, cells were incubated in 
secondary antibody for 60 min at room temperature, and subsequently stained for 5 min with 1× 
DAPI in PBS. Confocal imaging was performed using the Leica SP5X system with an upright 
DM6000 microscope, and images were processed with the Leica AF software suite. 
Immunofluorescence experiments were repeated at least two times in independent experiments. 
The following antibodies were used for immunofluorescence experiments: mouse anti-Myc (sc-40, 
Santa Cruz Biotechnology) and rabbit anti-NRIP1 (ab42125, Abcam), both diluted 1:100. Donkey 
anti-mouse secondary antibodies conjugated to Alexa Fluor 488 or 594 and donkey anti-rabbit 
secondary antibody conjugated to Alexa Fluor 594 were purchased from Invitrogen.  
 
Co-immunoprecipitation assays 
Co-immunoprecipitation experiments were performed using protein lysates from transfected 
HEK293 cells. Cell lysates were precleared with Protein G (? Or A) Sepharose beads (GE 
Healthcare -- CONFIRM) at 4°C overnight in IP lysis buffer (_____) containing Halt Protease 
Inhibitor Cocktail (Thermo Fisher Scientific) and EDTA (_____). Co-immunoprecipitation of Myc-
tagged proteins was performed using Myc agarose beads (Invitrogen?). The beads were washed 
five times with lysis buffer and proteins were eluted from the beads by incubating in loading buffer 
for 30min at 30°C (DOUBLE CHECK TIME AND TEMP).  Samples were analyzed by Western blot 
with anti-Myc (sc-40, Santa Cruz Biotechnology) and anti-FLAG (____, Sigma) antibodies at 
1:1000 dilution. Horseradish peroxidase (HRP)-labeled secondary antibodies were purchased from 
Santa Cruz Biotechnology. 10% of the input was loaded as a control. Experiments were repeated 
at least three times in independent experiments. 
 
Mice methods (in situ and RA dependency in explant cultures. ) 
Dear Andreas, please add methods text in relation to Fig 3C and Fig 4. Thanks! 
 
Methods : Xenopus laevis experiments SOEREN – please add text. Thanks! 
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RESULTS  
NRIP1 mutations cause CAKUT 
To identify a causative mutated gene for CAKUT we investigated a four-generation Yemenite 
Jewish family with seven individuals who have congenital anomalies of the kidneys and urinary 
tract (CAKUT). Renal dysplasia was the predominant phenotype (5 individuals) together with 
Vesicoureteral reflux (VUR) (4 individuals) and/or ectopia (2 individuals) (Fig. 1A & B, Table 1 and 
Supplementary Fig. 1). The age at diagnosis ranged from the prenatal period to late adulthood 
(Table 1). Two of the seven affected individuals underwent surgical intervention including unilateral 
nephrectomy for their malformations. None of the affected individuals had extra-renal 
malformations or syndromic features. The pedigree structure was compatible with an autosomal 
dominant mode of inheritance with variable expressivity and incomplete penetrance (Fig. 1A). 
Individual II:1 had renal US showing bilateral small renal cyst (Supplemental Fig. 1), which can be 
a common finding in his age group and is not necessarily related to the CAKUT phenotype in this 
family. Therefore, for the initial WES analysis, which considered affected only members, individual 
II:1 was not included.  Under the hypothesis that mutation of an autosomal dominant gene causes 
CAKUT in this family, we selected six affected family members (individuals III:3, III:4, III:5, IV:7, 
IV:8 and IV:9) for whole exome sequencing (WES). Given the pedigree structure (Figure 1A), the 
six affected individuals are expected to share about 3.125% of all alleles by descent, allowing us to 
reduce 32-fold the thousands of variants from normal reference sequence that are expected to 
result from WES (Table S1). We identified a heterozygous truncating mutation (c.279delG; 
p.Trp93fs*) in the gene encoding the Nuclear Receptor Interacting Protein 1 (NRIP1) [MIM 602490, 
RefSeq accession number NM_003489.3]  (Table 1 and Fig. 1C-D). Segregation analysis 
revealed that this mutation was shared by all seven available affected family members as well as 
by individual II:1, who as expected from the pedigree structure,  is an obligatory mutation carrier 
given that his brother (indevidual II:8) was found to have CAKUT on renal ultrasound (Fig. 1A and 
Table 1) and to harbor the NRIP1 mutation (Fig. 1A). In addition, the mutation was absent from all 
7 unaffected family members available for study, from all available databases of healthy controls 
(Table 1), as well as from two in-house control cohorts of 200 individuals with nephronophthisis 
and 429 individuals with nephrotic syndrome. Finally, we also showed by CNV analysis that the 
affected index patient (IV:8) lacked heterozygous deletions that have previously been associated 
with CAKUT in the HNF1B locus and the DiGeorge/velocarodiofacial syndrome locus.27   
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The NRIP1 mutation interferes with nuclear translocation, transcriptional repression, and 
NRIP1 interaction with RARα 
NRIP1 is a nuclear receptor transcriptional co-factor 28. Previous biochemical analyses showed 
that the murine NRIP1 protein harbors two putative nuclear localization signals (NLS) and four 
repression domains (RD) that mediate its transcriptional repression (ref) (Fig. 1C).  In addition, it 
has been shown to directly interact with the retinoic acid receptors (RAR and RXR) and to 
suppress their retinoic acid mediated transcriptional activity (Farooqui, 2003; ref). The NRIP1 
protein contains ten nuclear receptor interacting motifs (LxxLL) spread throughout the molecule 
(Fig. 1D) (Augereau, 2006). Interestingly, the binding of NRIP1 to retinoic acid receptors (RAR) 
and retinoic X receptors (RXR) was suggested to also require a slightly different sequence, an 
LxxML motif, located at the protein’s C-terminal end (Chen et al 2002). 
To examine how the c.279delG (p.Trp93*) mutation, which segregated with the CAKUT phenotype 
in the large family H conveys NRIP1 loss of function, we evaluated NRIP1 for its known functional 
features. These include: i) nuclear localization, ii) transcriptional repression,  and iii) interaction with 
retinoic acid receptor alpha (RARα). Transfection of expression constructs in HEK293 cells 
revealed that, whereas the wild-type NRIP1 protein translocated into the nucleus – the NRIP1 
altered protein (p.Trp93fs*) predominantly remained localized in the cytoplasm (Fig. 2A, 2B). In 
target cells, retinoic acid (RA), the active form of vitamin A, acts as a ligand for nuclear retinoic acid 
receptors (RARs) and retinoid X receptors (RXRs). The complex binds to a regulatory DNA 
segment, the RA response element (RARE), to control transcription of RA target genes (16. 
Cunningham, 2015). Accordingly, we next determined whether the NRIP1 mutation affects NRIP1 
retinoic acid dependent transcriptional activity using NRIP1 expression plasmids and a reporter 
plasmid harboring retinoic acid response elements (RARE) (ref). While the wild-type NRIP1 
expression construct acts as transciptional repressor, and completely supressed retinoic acid 
mediated transcriptional activity, the mutant construct (p.Trp93fs*) showed lack of transcriptional 
repressor activity (Fig. 2C).  
We previously showed that monogenic CAKUT can be secondary to a dominant negative 
pathomechanism. To test this possibility, using a luciferase reporter assay we co-transfected 
NRIP1 wild-type construct with increasing amounts of the mutant NRIP1. This did not yield a dose-
dependent lack of repression, thereby not supporting a dominant negative effect of the mutant 
protein on transcriptional activity of the wild type protein (Supplemental Fig. 2). Furthermore, 
since proteins that hetero/homo dimerize are particularly prone, when altered, to exert dominant-
negative effects by sequestering functioning molecules into inactive dimers, we tested the 
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interaction between the altered NRIP1 protein and retinoic acid receptor alpha. Notably, the altered 
NRIP1 protein still contains one intact interaction motif (Fig. 1C), which, according to previously 
solved ligand binding domains crystalized structures (ref), may theoretically be sufficient to interact 
with the nuclear receptor ligand binding domain of the RARα (ref). We performed overexpression 
experiments of RARα with either wild-type or mutant NRIP1. Interestingly, the wild-type NRIP1 
protein co-localizes with RARα in a speckled nuclear pattern, while, when over-expressed with the 
altered NRIP1 protein, RARα localized diffusely in the nucleus while the mutant NRIP1 remained in 
the cytoplasm (Fig. 2D), making a dominant negative pathomechanism unlikely. Furthermore, by 
co-immunoprecipitation experiments we show that the NRIP1 mutation abrogates NRIP1-RARα 
interaction (Fig. 3A-B), again arguing against a dominant negative pathomechanism. 
 
Retinoic acid increases NRIP1 binding to RARα in vitro and increases NRIP1 mRNA 
expression in mouse explant organ cultures 
Formation of the ureter and kidney begins with ureteric budding when this epithelial tube sprouts 
from the base of the Wolffian ducts just above the urogenital sinus - an embryonic structure which 
will eventually give rise to the urinary bladder. Distally the ureteric bud invades the renal 
metanephric mesenchyme and, following successive branching, gives rise to the renal collecting 
duct system. The ureteric bud stalk differentiates into the ureter, and its proximal part is transposed 
to the primitive bladder via the common nephric duct. Elegant studies have shown that the 
common nephric duct undergoes apoptosis thereby severing connections with the Wolffian duct as 
the ureter orifice is transposed to its final insertion site in the bladder ureter (Batourina, 2005). This 
crucial step is controlled by retinoic acid induced signals which govern ureter maturation and 
formation of proper connections between the bladder and ureter (Batourina, 2005).  
In order to further characterize the role of NRIP1 in retinoic acid signaling, we first aimed to 
determine whether NRIP1 is expressed in retinoic acid dependent tissue in the development of the 
murine urogenital system. We performed RNA in situ hybridization on whole-mount preparations of 
urogenital systems of E11.5 to E18.5 mouse embryos and on sections of the urogenital system at 
E11.5 to E18.5. Strikingly, Nrip1 enhanced expression was found in the nephric duct, ureter and 
collecting duct at very early developmental stages (Fig. 4).  Next, we tested for NRIP1 retinoic acid 
dependency with respect to NRIP1 expression and interaction with retinoic acid receptor alpha. 
Our results suggest that in Nrip1 expression is enhanced by retinoic acid (Fig. 3C), thereby 
identifying it as a novel retinoic acid-responsive gene (Fig. 3C). In addition, the binding of NRIP1 
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with retinoic acid receptor α, was enhanced in the presence of retinoic acid treatment done on 
transfected HEK293 cells (Fig. 3A2).  
 
Functional in vivo studies in Xenopus laevis show a major role for NRIP1 during renal 
development which is abolished with the mutant NRIP1 
 
Expression and knockdown experiments in Xenopus laevis further confirmed a role for NRIP1 in 
renal development. Since unilateral injections allow a tissue restricted knockdown and analysis of 
organ specific phenotypes, we turned to the Xenopus model to analyze the developmental events 
in renal formation in further detail. Nrip1 is expressed during Xenopus development, and was 
enriched within the renal tubules (Fig. 5). Knock down with a translation blocking nrip1 MO 
inhibited pronephros development and resulted in distorted structure of the pronephrones (h/k; 
p<0,001). This  could partially be rescued with NRIP1 wt (i/k; p=0,007) but not with NRIP1 G279 
del (j/k; p=0,429) (Fig. 6). These data support the role of Nrip1 during early tubular 
morphogenesis, and is consistent with the human CAKUT phenotype. 
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DISCUSSION  
We here identify a truncating mutation of NRIP1 as a novel autosomal dominant cause of human 
CAKUT. By studing NRIP1 cellular localization, luciferase assay, and protein-protein interaction, 
we demonstrate loss of function for  truncating NRIP1 mutation that segregated in a large CAKUT 
pedegree. We generated additional data that suggest that dysregulation of NRIP1 dependent 
retinoic acid signaling during kidney and ureter morphogenesis causes CAKUT. Furthermore, by 
expression and knockdown experiments in Xenopus laevis we further confirmed a role for NRIP1 in 
renal development and the role of NRIP mutation as a novel cause of CAKUT in humans.  
 
Nuclear receptor-interacting protein 1 (NRIP1), also known as receptor-interacting protein 140 
(RIP140) (ref), is a transcriptional co-regulator, which has been shown to play a role in fine tuning 
of the activity of large number of transcription factors during development (ref). NRIP1 was mainly 
implicated as a corepressor of gene expression by interacting with different nuclear receptors, 
including the retinoic acid receptors (ref, ref). Nonetheless, the role of NRIP1 during kidney and 
ureter development as well as its relation to retinoic acid (the active form of vitamin A) in this 
context has been largely unknown. In the current study, our finding of a germline NRIP1 mutation 
as a novel cause of human CAKUT provides a link between the well documented association, of 
vitamin A/retinoic acid and renal malformations (Wilson, 1948; Batourina, 2005 ref).   
 
Retinoic acid is a signaling molucule crucial for the embryonic formation of many  organs (Duester 
G 2008, Cell). Whithin human (ref) as well as rodent (ref) embryos, axcess  or deficiency of retinoic 
acid, cause CAKUT. Classic mouse models studies have highlighted the importance of retinoic 
acid signaling for proper ureter maturation and ureter-bladder connection (ref ref ref). Perturbation 
of this process in mice can result in hypo/dysplastic kidneys as well as in backflow of urine to the 
ureters, clinically known as vesicoureteral reflux (VUR). Interestingly, renal dysplasia and VUR 
were both the predominant phenotypes in the kindred we studied here (Fig. 1., Table 1).  Our 
results suggest that NRIP1 inhibits retinoic acid-induced transcription. In turn, NRIP1, a target 
gene of retinoic acid, serves as a feedback inhibitor for this pathway. We postulate that loss of this 
feedback inhibition may mimic retinoic acid excess as described in the CAKUT mice models (ref), 
thereby leading to renal malformations. 
  
Our study highlights several insights with respect to the complex genetic basis of CAKUT 
(ref,Knores). In addition to genetic heterogeneity, low penetrance mutations, and a variable 
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expressivity already described in monogenic CAKUT, our results emphasize possible gene-
environment interactions as an additional level of complexity in human CAKUT.  
 
NRIP1 mutations have never been implicated before in a human disease. Furthermore, early 
NRIP1 truncating mutations are absent from all available WES databases, supporting intolerance 
for this gene for loss of function (see Exac: pLI score of 0.99). This is consistent with our finding 
that the early truncating NRIP1 mutation which we identified results in a haploinsufficiency 
pathomechanism rather than a dominant negative effect. The fact that we did not find a second 
CAKUT family with NRIP1 mutations supports the general notion that CAKUT is probably caused 
by very large number of different and extremely rare disease-causing mutations in large number of 
different genes (vivante rev). 
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Supplemental Data include 2 figures and 1 table. 
 
Acknowledgments 
We are grateful the family who contributed to this study. We thank XXX for contributing renal 
pathology, radiology and clinical materials. We thank Lina wei for providing us with RARE 
luciferase reporter. This research was supported by grants from the National Institutes of Health to 
R.P.L (?), to and to F.H. (DK088767), and from the March of Dimes to F.H. A.V. is a recipient of 
the Fulbright postdoctoral scholar award for 2013 and is also supported by grants from the Manton 
Center Fellowship Program, Boston Children's Hospital, Boston, Massachusetts, USA, and the 
Mallinckrodt Research Fellowship Award. R.P.L. is an Investigators of the Howard Hughes Medical 
Institute. F.H. is the Warren E. Grupe Professor of Pediatrics at Harvard Medical School.  
 
Web Resources 
http://www.renalgenes.org 
UCSC Genome Browser, http://genome.ucsc.edu/ cgi-bin/hgGateway 
1000 Genomes Browser, http://browser.1000genomes.org.  
Ensembl Genome Browser, http://www.ensembl.org. 
Exome Variant Server, http://evs.gs.washington.edu/ EVS. 
Polyphen2, http://genetics.bwh.harvard.edu/pph2. SeattleSeq  
Sorting Intolerant From Tolerant (SIFT), http://sift.bii.astar.edu.sg.  
Online Mendelian Inheritance in Man (OMIM), http://www. omim.org/ 
ExAC Browser Beta, http://exac.broadinstitute.org 
Gudmap (GenitoUrinary Molecular Anatomy Project), http://www.gudmap.org 
http://www.mutationtaster.org/ 
 
 
 
 
 
 
 15 
FIGURE LEGENDS 
 
Figure 1. Identification of NRIP1 mutation in index Family H with CAKUT. 
Panel A shows the pedigree of index family H. Squares represent males, circles females, black 
symbols affected persons, white symbols unaffected persons and white symbol with black dot 
denotes obligatory mutation carrier. Pedigree is compatible with an autosomal dominant mode of 
inheritance with incomplete penetrance and variable expressivity. Roman numerals denote 
generations. Individuals are numbered with Arabic numerals if DNA was available for study. The 
arrow points to the proband IV:8.  WT denotes the wild-type allele. p.Trp93* indicates the mutation 
c.279 deletion of G in NRIP1, leading to a frame shift mutation and introducing a premature stop 
codon. The mutation fully segregated heterozygously (WT / p.Trp93*) across all seven affected 
individuals examined and was absent from seven unaffected family members available for study 
(WT / WT). Individual II:1, is an obligatory mutation carrier given the pedigree structure and 
segregation analysis. Red circles indicate the persons selected for whole exome sequencing 
analysis.  
Panel B shows voiding cystourethrogram (VCUG) (left panel) and renal ultrasound (right panel) of 
the index individual IV:8,  revealing severe grade 5 left vesicoureteral reflux and hydroureter (white 
arrows). The index case presented during infancy following screening and is managed expectantly.  
He had no extra renal manifestations. 
Panel C shows exon structure of human NRIP1 cDNA and domain structure of the nuclear 
receptor interacting protein 1 (NRIP1) protein. NRIP1 contains two putative nuclear localization 
signals (blue); four transcriptional repression domains (RD, yellow), and 10 interaction motifs 
LxxLL/LxxML (red & orange). Start codon (ATG) and stop codon (TAA) are indicated. 
Panel D shows chromatograms of the heterozygous mutation detected in NRIP1 (in relation to 
exons and protein domains) in the index family (red) with CAKUT. The index family’s heterozygous 
mutation c.279delG leads to a frameshift and premature stop codon resulting in p.Trp93fs*.     
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Figure 2. NRIP1 p.Trp93fs* fails to translocate to the nucleus, does not suppress RA 
activation and fails to interact with retinoic acid a receptor alpha (RARα). 
Panel A: Immunofluorescence staining of HEK293 cells transfected with Myc-tagged wild-type 
(WT) NRIP1 and Myc-tagged NRIP1 p.Trp93fs*. WT NRIP1 localizes to the nucleus, while the 
altered NRIP1 protein remains predominantly localized in the cytoplasm. 
Panel B: Western blot of cytoplasmic (C) and nuclear (N) extracts from transfected HEK293 cells 
showing localization of WT NRIP1 predominantly in the nucleus (Anti-Sp1) and NRIP1 p.Trp93fs* 
in the cytoplasm (Anti-GAPDH). 
Panel C: Luciferase assay of HEK293 cell transfected with Mock GFP, GFP-tagged WT NRIP1, 
and GFP-tagged NRIP1 p.Trp93fs* mutant and subsequently treated with retinoic acid. WT NRIP1 
suppresses retinoic acid induced transcriptional activity while the mutant form fails to do so. 
Panel D: Immunofluorescence staining of HEK293 cells co-transfected with GFP-tagged RARα 
and either Mock Myc, Myc-tagged WT NRIP1, or Myc-tagged NRIP1 Trp93fs*. RARα and WT 
NRIP1 co-localize in the nucleus (speckled pattern), while the Trp93fs* mutant protein remains in 
the cytoplasm.   ** p<0.01; NS, not significant.   
 
 
Figure 3. Retinoic acid increases NRIP1 binding to RARα in vitro and increases NRIP1 
mRNA expression in mouse kidney explant organ cultures. 
Panel A: Co-immunoprecipitation of protein lysates of WT NRIP1 and RARα overexpressed in 
HEK293 cells. Treatment with RA increases WT NRIP1 binding to RARα (orange boxes). The 
Trp93fs* mutation abrogates binding to RARα.   
Panel B: Quantification of data shown in Panel A. RARα co-immunoprecipitation band intensity 
was normalized to WT NRIP1 immunoprecipitation band intensity in the absence and presence of 
retinoic acid. * p<0.05, average of 3 separate experiments. 
Panel C: NRIP1 mRNA is downregulated after treatment with the RA antagonist, BMS493, and 
upregulated following treatment with retinoic acid (Andreas please give concentrations).  
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Figure 4. Nrip1 shows specific early expression in the Wolffian (nephric) duct, ureter, and 
collecting duct epithelium of the developing urogenital system of the mouse. 
Comparative in-situ hybridization analysis of expression of Nrip1 in whole urogenital systems and 
on sections of E11.5, E12.5, E14.5, and E18.5 wild-type urogenital systems. At least three 
independent specimens were analyzed each. 
bl, bladder; cd, collecting duct; cl, cloacae; k, kidney; t, testicular duct; u, ureter (stalk);um, ureteric 
mesenchyme; ue, ureteric epithelium; ut, ureteric tip; wd, Wolffian duct. 
 
Figure 5: Nrip1 deficiency affects pronephros development in Xenopus. 
(a-c) Whole mount in situ hybridization of nrip1 in X. laevis shows its occurrence in the pronephros 
during development. Expression starts in the pronephric anlage at stage 24 (a, a’) and is present in 
the tubules of stage 33 tadpoles (c, c’). 
(d-k) Functional analysis of nrip1 in X. laevis. Embryos were unilaterally injected with nrip1 MO 
and/ or NRIP1 encoding mRNA at the 4-cell stage. Stage 39 tadpoles were stained with fluorescein 
conjugated lectin to visualize the pronephros (d-j). The size of the pronephros was measured and 
the proportion between the injected (right) and uninjected (left) side calculated (k). The structure of 
the pronephros was not changed by microinjections of the NRIP1 wt (e/ k) mRNA or its truncated 
variant (NRIP1 G279 del; f) compared to the controls (d’/k).  Knock down with a translation 
blocking nrip1 MO inhibited pronephros  development (h/k; p<0,001) and could partially be rescued 
with NRIP1 wt (i/k; p=0,007) but not with NRIP1 G279 del (j/k; p=0,429). Error bars represent SEM. 
** p<0.01, ***p<0.001 (MWU-test) 
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Table 1.  Dominant NRIP1 mutations detected in individuals with congenital anomalies of the kidneys and urinary tract.a 
 
Family 
 - 
individual 
Ancestry Nucleotide  
alteration
a 
 
Exon 
(zygosity) 
 
Alteration  
in coding 
sequence
a
 
Allelic loss 
of function 
(nuclear 
localization/ 
luciferase/ 
Co-IP with 
RARα) 
a,c 
Presenting 
symptoms or 
diagnostic test 
(at age in years) 
Kidney 
phenotype 
Treatment Serum 
creatinine 
[mg/dL] 
(at age in 
years) 
H 
 
  
  II:8 
 
 
  III:3 
 
 
  III:4 
 
 
  III:5 
 
 
  IV:7 
 
 
  IV:8 
 
 
  IV:9 
 
 
Yemeni 
Jews 
 
 
 
 
 
c.279delG 
 
 
c.279delG 
 
 
c.279delG 
 
 
c.279delG 
 
 
c.279delG 
 
 
c.279delG 
 
 
c.279delG 
 
 
 
7 (het) 
 
 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
p.Trp93fs* 
 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
(+/+/+) 
 
 
 
 
 
 
Renal US (58) 
 
 
Abdominal 
mass 
(newborn) 
Abdominal pain 
(7) 
 
Renal US (3) 
 
 
Renal US (2) 
 
 
Hydronephrosis 
on renal US 
(prenatal) 
 
Renal US 
(prenatal) 
 
 
 
 
 
R  small pelvic kidney with 
hydronephrosis 
 
L MCDK; R VUR, dilated 
ureter and dysplasia 
 
L dysplastic kidney and  
VUR 
 
Bilateral grade 2 VUR 
 
 
Small right kidney 
 
 
L VUR grade 5 and 
dysplasia; R VUR grade 2 
 
L ectopic dysplastic Kidney 
 
 
 
 
 
Conservative 
 
 
L nephrectomy 
 R nephrostomy  
   
L nephrectomy 
 
 
Conservative 
 
 
Conservative 
 
 
Conservative 
 
 
Conservative 
 
 
 
 
normal 
 
 
1.5 (35) 
 
 
0.75 (27) 
 
 
0.64 (28) 
 
 
normal 
 
 
normal 
 
 
normal 
 
 
a
cDNA mutations are numbered according to human cDNA reference sequence NM_003489.3, isoform (NRIP1), where +1 corresponds to the A of ATG start translation.  
b
Mutation was absent from 200 control individuals with renal ciliopathies, 429 individuals with steroid-resistant nephrotic syndrome, from ~13,000 healthy control alleles of the 
EVS (exome variant server http://evs.gs.washington.edu/EVS), from and 2,577 control individuals of the “1,000 human genomes project” (http://www.1000genomes.org), and 
from ~112,000 control chromosomes of the ExAC server (http://exac.broadinstitute.org). 
 
c
 “+” indicates a defect of the allele in one of the 3 assays of NRIP1 function: Nuclear localization (Fig. 2A), luciferase assay (Fig. 2C) or Co-IP with RARα (Fig. 3A).  
 
Co-IP, co immunoprecipitation; het, heterozygous;L, left;  MCDK, multicystic dysplastic kidney; NA, not applicable; ND, no data; R, right; US, ultrasound; VUR, vesicoureteral 
reflux. 
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